Therapy with THC Eradicates Nightmares in Over a Quarter of PTSD Patients

Beating Nightmares in PTSD Patients

A remarkable discovery has been made in the treatment of PTSD, a condition that can leave people severely impaired and affect their quality of life. Nightmares are one of the most distressing symptoms of PTSD, which can occur after a person experiences a traumatic event, such as a severe accident, violence, or a conflict.

Health news

APOE Genotype Influences How Well Blood Tau Protein Predicts Cognitive DeclinePancreatic Cancer Hijacks Blood-Clotting System to Evade Immune AttackSurvey Reveals Most Men Unaware Dairy May Increase Prostate Cancer RiskTherapeutic Gardening Shows Promise for Mental Health in Adults with Chronic Illnesses

During sleep, people with PTSD can relive the traumatic event in vivid detail. These repetitive episodes can cause severe sleep deprivation and make some individuals afraid to go to bed. Current medications available on the market often provide limited relief from trauma-related nightmares. In this context, researchers at Charité – Universitätsmedizin Berlin investigated whether a prescribed medication containing THC, one of the active compounds found in cannabis, could offer a solution.

A New Hope for PTSD Patients

The study, published in Nature Medicine, found that over half of the participants responded to the treatment. More than a quarter of the patients reported that their nightmares had completely disappeared after 10 weeks. PTSD symptoms can be extremely challenging to treat due to the lasting impact of traumatic events on a person's life. In PTSD, the brain struggles to process traumatic events, causing memories to be stored in a way that triggers involuntary and uncontrollable recurrences.

THC: A Potential Breakthrough in PTSD Treatment

These symptoms can occur both during the day and at night. During sleep, people with PTSD can relive the trauma repeatedly until they wake up in a state of panic. Antidepressants and blood pressure-lowering medications are often used to treat PTSD, but their effectiveness is limited. Moreover, these medications do little to alleviate nightmares. Germany has not yet approved a specific medication for trauma-related nightmares. Professor Stefan Röpke studies trauma-related disorders at the Department of Psychiatry and Neurosciences on the Benjamin Franklin campus of Charité. In exploring new treatments, he and his team, in collaboration with other research partners, drew attention to tetrahydrocannabinol, commonly known as THC.

THC interacts with the body's endocannabinoid system, which helps regulate sleep, stress, and emotional memory processing. Professor Stefan Röpke explains, „There is evidence suggesting that during REM sleep, THC can help prevent the recurrence of traumatic episodes.”The study's results were remarkable, with over a quarter of patients with PTSD reporting that their nightmares had completely disappeared after treatment with THC. These findings may indicate that THC treatment could be a viable solution for one of the most distressing symptoms of PTSD.